When Ren Menon and Nicole Garcia noticed the growth in direct-to-consumer companies for dental needs, they believed that the clear aligner market was being overlooked.
“We were worried about the lack of dentist involvement in the direct-to-consumer clear aligner model,” said Menon, CEO of OrthoFX. He and Garcia, president of OrthoFX, cofounded the company with Henry Chan. “We wanted to bring the doctor back into the hub of the model while still involving patients in their care.”
The trio developed their idea for a company where the dentist is more involved, and where both dentists and patients have a great experience. “People expect a high-quality digital experience that’s connected and safe,” they agreed. “We provide that and more."
In this interview with Dr. Pamela Maragliano-Muniz, Menon and Garcia explain that the majority of OrthoFX treatments end on time and that 80% need no refinements. “Patients started calling us the Tempur-Pedic of teeth because of the comfort of the materials we use, and we sort of adopted that nickname,” Menon said.
One of the most important aspects of OrthoFX is that it gives dentists the ability to monitor patient compliance. Find out some of the other advantages of OrthoFX clear aligner therapy in this interview.
For more informative and up-to-the-minute video chats with key industry experts, visit DentistryIQ Videos.
Pamela Maragliano-Muniz, DMD, is the chief editor of DentistryIQ and editorial co-director of Through the Loupes. Based in Salem, Massachusetts, Dr. Maragliano-Muniz began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano-Muniz owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected].
